Clinical trial · Interventional
Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma
NCT00769535CI-TRIAL-00010165HSP70completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Polymorphisms of HSP70 and tumor necrosis factor-alpha promoter in patients with hepatocellular carcinoma, chronic liver disease and healthy controls will be measured by PCR-RFLP or direct sequencing. The clinical relevance of patients will be compared in those with polymorphism and those without.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Polymorphisms of HSP70 and TNF promoter | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HSP70 and TNF polymorphisms
- interventionNames
- Genetic: Polymorphisms of HSP70 and TNF promoter
Primary outcomes (1)
- measure
- Clinical relevance
- timeFrame
- year
Secondary outcomes (1)
- measure
- Clinical relevance
- timeFrame
- year
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * History proven HCC patients Exclusion Criteria: * No-definite diagnosed patients
References
Publications (0)
Data not yet available
No reference posted for this study.